29 Apr 2024 CMB International Global Markets | Equity Research | Company Update Alphabet (GOOG US) 1Q24 earnings beat on efficiency gain; GenAI development on track Alphabet announced 1Q24 results: total revenue grew by 15% YoY to US$80.5bn, in line with consensus estimate; GAAP net income was up 57% YoY to US$23.7bn, 21% ahead of consensus estimate, thanks to Alphabet's organization optimization which leads to greater velocity and efficiency. The company further raised its shareholder return, announcing a ...

Investment Rating - The report maintains a BUY rating for GAC Group with a target price of HK$5.50, indicating a potential upside of 69.2% from the current price of HK$3.25 [5][10]. Core Insights - GAC Group's 1Q24 earnings were largely in line with prior estimates, with a net profit of RMB1.2 billion, which was about RMB166 million lower than previous forecasts. The company maintains its FY24E net profit forecast at RMB5.4 billion [2][11]. - The report expresses a conservative outlook on Aion's sales volume and profitability, suggesting that quality growth through brand upscale and overseas expansion is crucial for long-term development [2][3]. - Trumpchi's PHEV sales growth is highlighted as a potential area of investor interest, with management expecting substantial year-on-year net profit growth in FY24E despite a competitive pricing environment [2][3]. Financial Performance Summary - GAC Group's 1Q24 revenue was RMB21.6 billion, reflecting an 18.8% year-on-year decline, while gross profit was RMB1.1 billion, showing an 85.5% increase year-on-year [7][11]. - The company reported a gross margin of 5.2% in 1Q24, which is an improvement of 2.9 percentage points year-on-year [7]. - For FY24E, revenue is projected at RMB139.57 billion, with a gross profit of RMB7.21 billion and a net profit of RMB5.41 billion, indicating a 22.1% growth in net profit year-on-year [8][9]. Valuation and Estimates - The report employs a sum-of-the-parts (SOTP) valuation, estimating Aion's value at HK$3.3 per share and valuing joint ventures and associates at HK$2.2 per share [10]. - The FY24E equity income forecast is maintained at RMB8.3 billion, with expectations for flat performance in FY24E without restructuring burdens [2][3]. - The report includes FY26E estimates, projecting revenue growth to RMB152.64 billion, with a gross profit margin of 8.4% [8][9].

Investment Rating - The report maintains a HOLD rating for SANY Heavy with a new target price of RMB14.80, revised from RMB12.30, based on a 24x 2024E P/E ratio [2][3]. Core Insights - SANY Heavy's net profit for 2023 was RMB4.53 billion, a 6% year-over-year increase, but 12% below estimates. The 1Q24 net profit grew only 5% year-over-year to RMB1.58 billion, attributed to a revenue decline of 1% year-over-year [2][3]. - Concerns persist regarding a potential slowdown in exports, particularly in Europe, impacting overall performance [2][3]. - The report anticipates a moderate recovery in the Chinese market, leading to an 8% increase in 2025E earnings estimates, although these remain 24% to 29% below consensus [2][3]. Financial Performance Summary - **2023 Results**: Revenue decreased by 17% year-over-year to RMB17.9 billion, with a gross margin contraction of 1.9 percentage points to 25.6%. Net profit fell by 29% year-over-year to RMB480 million [2][3]. - **1Q24 Results**: Revenue dropped 1% year-over-year, but gross margin improved by 0.5 percentage points to 28.4%. Operating cash flow significantly improved to RMB4.38 billion compared to -RMB1.6 billion in 1Q23 [2][3]. - **Overseas Revenue**: In 2H23, overseas revenue (62% of total) grew 4% year-over-year to RMB20.8 billion, with Europe showing a 15% increase to RMB8.1 billion [2][3][7]. Valuation and Market Outlook - The target price of RMB14.80 reflects a valuation that is 0.5 standard deviations above the average P/E of 20x since 2017, indicating initial signs of stabilization in excavator sales in China [2][3]. - Upside risks include stabilization in property investment in China, while downside risks involve further declines in overseas demand [2][3].

M N 29 Apr 2024 CMB International Global Markets | Equity Research | Company Update Tigermed (300347 CH) Meaningful demand recovery in 1Q24 Target Price RMB66.82 Tigermed reported 1Q24 revenue of RMB1,660mn, down 8.0% YoY, and (Previous TP RMB68.57) attributable recurring net income of RMB303mn, down 20.5% YoY, which was Up/Downside 15.8% mainly due to the substantially reduced gains on fair value changes and Current Price RMB57.70 investment changes (RMB8mn in 1Q24 vs RMB198mn in 1Q23). 1Q24 revenue / attr ...

M N 2024 年 4 月 29 日 招银国际环球市场 | 睿智投资 | 公司更新 固生堂 (2273 HK) 1Q24 保持业务快速增长势头 目标价 71.96港元 固生堂更新了 1Q24 经营数据， 1Q24 就诊人次约为 107 万，同比增长约 (此前目标价 71.96港元) 42.1%，其中在23年4月1日至24年3月31日期间新成立的门店1Q24就诊 潜在升幅 58.2% 人次约为 7.4 万，贡献总就诊人次增长率中的 9.8%。管理层表示老店就诊人次 当前股价 45.50港元 增长达 32.2%。门诊人次的强劲增长部分得益于 23 年 1-2 月疫情导致的低基 中国医药 数，然而23年3月出现积压需求的集中爆发，造成一定的高基数，但24年3月 武 煜, CFA 门诊人次的增长仍超过 30%。同时，管理层表示 1Q24 客单价同比增长超过 (852) 3900 0842 2%。基于公司良好的现金流表现，管理层计划在未来 3-5 年将每年的分红、回 jillwu@cmbi.com.hk 购的比例提高至净利润的30-50%，以更好的回馈股东。 黄本晨, CFA  线下门店扩张提速。23 年固生堂共收 ...

| --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------| | | | | CMB International Global Markets Address : 45/F, Champion Tower, 3 Garden Road, Hong Kong, Tel: (852) 3900 0888 Fax: (852) 3900 0800 | Limited | | CMB International Global Markets subsidiary of China Merchants Bank) | Limited ("CMBIGM") i ...

Meta reported 1Q24 results: total revenue grew by 27% YoY to US$36.5bn, in line with consensus estimate of US$36.2bn; net income was up 117% YoY to US$12.4bn, also in line with consensus estimate (US$12.2bn). For 2Q24, management guides total revenue to increase by 14-22% YoY to US$36.5- 39.0bn (vs. consensus estimate of US$38.3bn), with growth rate normalizing as the base effect wanes. Looking ahead, Meta expects to start a multi-year investment cycle to build full-scale AI capabilities and enhance monetiz ...

Investment Rating - The report maintains a BUY rating for Vesync with a target price of HK$ 6.79, based on a P/E of 11x for FY24E, reflecting a potential upside of 57% from the current price of HK$ 4.33 [2][5][15]. Core Insights - Despite slow sales growth in 1Q24, the end-demand remains healthy, supported by a strong sell-out growth and low inventory levels in the Amazon channel. The company expects orders growth to normalize in the upcoming quarters [2][8]. - The management has reiterated its FY24E guidance of over 20% sales growth and over 10% net profit margin, which aligns with the analyst's conservative positive outlook [2][8]. - The report highlights that Vesync's gross sales growth was only 1% in 1Q24, attributed to supply issues and reduced orders from Amazon, while non-Amazon channels saw a significant growth of 38% [2][8]. Financial Summary - Revenue is projected to grow from US$ 585 million in FY23 to US$ 675 million in FY24, representing a year-over-year growth of 15.3% [3][14]. - Net profit is expected to increase from US$ 77.4 million in FY23 to US$ 91.4 million in FY24, with a net profit margin improvement from 13.2% to 13.5% [3][14]. - The gross profit margin is anticipated to stabilize at 46.0% in FY24, slightly down from 46.9% in FY23, while the operating profit margin is expected to be around 15.3% [3][14]. Growth Outlook - The report projects a compound annual growth rate (CAGR) of 13% for sales and 16% for net profit from FY23 to FY26E, indicating robust growth potential [2][8]. - Specific brands under Vesync, such as Levoit and Cosori, are expected to achieve sales growth of 15% in FY24E, driven by new product launches and category expansions [8][10]. Valuation Metrics - The current valuation of Vesync at 7x FY24E P/E is considered attractive compared to its historical average of 12x, suggesting a favorable investment opportunity [2][5][15]. - The report notes that the average inventory days for major retailers have decreased, indicating improved channel inventory health, which bodes well for future sales [8][10].

M N 26 Apr 2024 CMB International Global Markets | Equity Research | Company Update Luxshare (002475 CH) FY23 in-line with better-than-feared 1H24 earnings guidance; Solid outlook ahead Target Price RMB46.61 Luxshare posted FY23 revenue/NP growth of 8%/20% YoY, largely in-line with (Previous TP RMB46.96) pre-announcement of 20-25% YoY, while 1H24E earnings guidance of 20-25% Up/Downside 63.3% YoY (implying 2Q24E 18%-27% YoY) is above market expectations. We believe Current Price RMB28.54 the strong 1H24 out ...

Investment Rating - The report maintains a "Buy" rating for iQIYI with a target price of $8.60, indicating a potential upside of 87.8% from the current price of $4.58 [4]. Core Insights - iQIYI is focusing on high-quality and diversified content while expanding into overseas markets and targeting the elderly and youth demographics. The management emphasizes a return to realism in content creation and the importance of AIGC (Artificial Intelligence Generated Content) in enhancing creator value [2][3]. - The company has announced over 300 new titles, including popular series and genres, which are expected to drive membership growth and improve profitability [2][3]. - The report anticipates a recovery in advertising revenue driven by innovative variety shows and operational improvements [2]. Financial Summary - Sales revenue is projected to grow from 31,873 million RMB in 2022 to 39,960 million RMB in 2026, reflecting a compound annual growth rate (CAGR) of approximately 6% [3][13]. - Adjusted net profit is expected to increase from 2,811.2 million RMB in 2023 to 4,543.2 million RMB in 2026, indicating a positive trend in profitability [3][13]. - The diluted earnings per share (EPS) is forecasted to rise from 4.28 RMB in 2023 to 4.66 RMB in 2026, showcasing an upward trajectory in earnings [3][13]. Content Pipeline - iQIYI has a robust pipeline with over 300 new titles across various genres, including dramas, variety shows, and films, set to launch in 2024. Notable upcoming series include "Cloud Rising" and "The Heart of the World" [2][8][12]. - The company is introducing new content units such as "Micro Dust Theater" and "Big Literature Theater" to cater to diverse audience preferences [2]. Market Position - iQIYI's market capitalization is approximately $4.395 billion, with a 52-week stock price range of $3.17 to $6.34, indicating volatility but also potential for growth [5]. - The average market estimate for EPS shows a significant increase from 0.37 RMB in 2021 to 3.37 RMB in 2026, reflecting positive market sentiment towards the company's growth prospects [3].